Patents Assigned to Merck Patents GmbH
  • Publication number: 20170371186
    Abstract: An optical switching device comprising a polarisation layer and a switching layer which comprises a liquid-crystalline material and a dye compound. Use of the optical switching device for the regulation of the passage of light through an area element. A window element which has the optical switching device therein.
    Type: Application
    Filed: June 21, 2017
    Publication date: December 28, 2017
    Applicant: Merck Patent GmbH
    Inventors: Michael JUNGE, Andreas BEYER, Mila FISCHER
  • Patent number: 9850255
    Abstract: The invention provides novel imidazol-piperidinyl derivatives of the formula (I) in which R1, R2, W, X1, X2, X3, X4 and n have the meanings indicated in formula I, and their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.
    Type: Grant
    Filed: September 27, 2016
    Date of Patent: December 26, 2017
    Assignee: Merck Patent GmbH
    Inventors: Ruoxi Lan, Bayard R. Huck, Xiaoling Chen, Yufang Xiao
  • Patent number: 9853228
    Abstract: The present invention relates to metal complexes and to electronic devices, in particular organic electroluminescent devices, comprising these metal complexes.
    Type: Grant
    Filed: July 3, 2015
    Date of Patent: December 26, 2017
    Assignee: MERCK PATENT GMBH
    Inventors: Nils Koenen, Philipp Stoessel, Anna Hayer, Holger Heil, Philipp Harbach
  • Patent number: 9850384
    Abstract: The present invention relates to transparent, electrically semiconducting interference pigments having high color strength, and in particular to flake-form interference pigments which comprise an oxygen-deficient layer of TiO2-x, to a process for the preparation of such pigments, and to the use of the pigments prepared in this way.
    Type: Grant
    Filed: May 28, 2014
    Date of Patent: December 26, 2017
    Assignee: MERCK PATENT GMBH
    Inventor: Reinhold Rueger
  • Publication number: 20170365786
    Abstract: The present invention relates to compositions comprising at least one polymer which contains triarylamine repeating units, and at least one metal complex, to methods for the production thereof, and the use thereof in electronic devices, especially in organic electroluminescent devices, so-called OLEDs (OLED=Organic Light Emitting Diode).
    Type: Application
    Filed: December 4, 2015
    Publication date: December 21, 2017
    Applicant: Merck Patent GmbH
    Inventors: Katja Stegmaier, Fabrice Eckes, Holger Heil, Henning Seim
  • Publication number: 20170362505
    Abstract: Compounds containing at least one C—C triple bond within a chain of at least 3 ring systems which have positive dielectric anisotropy, the use thereof for high-frequency components, liquid-crystalline media containing these compounds, and high-frequency components, in particular antennae, especially for the gigahertz region, containing these media. The liquid-crystalline media serve, for example, for the phase shifting of microwaves for tuneable phased-array antennae.
    Type: Application
    Filed: August 30, 2017
    Publication date: December 21, 2017
    Applicant: Merck Patent GmbH
    Inventors: Christian JASPER, Constanze BROCKE, Detlef PAULUTH, Volker REIFFENRATH, Atsutaka MANABE
  • Publication number: 20170365734
    Abstract: The present invention relates to a process for the production of structured, highly efficient solar cells and of photovoltaic elements which have regions of different doping. The invention likewise relates to the solar cells having increased efficiency produced in this way.
    Type: Application
    Filed: December 1, 2015
    Publication date: December 21, 2017
    Applicant: MERCK PATENT GMBH
    Inventors: Oliver DOLL, Ingo KOEHLER, Sebastian BARTH
  • Publication number: 20170365785
    Abstract: The present invention relates to compositions comprising at least one polymer containing repeat triarylamine units and comprising at least one salt, to processes for production thereof and to the use thereof in electronic devices, especially in organic electroluminescent devices, called OLEDs (OLED=organic light-emitting diodes). The present invention also further relates to organic electroluminescent devices comprising these compositions.
    Type: Application
    Filed: December 8, 2015
    Publication date: December 21, 2017
    Applicant: Merck Patent GmbH
    Inventors: Fabrice Eckes, Katja Stegmaier, Holger Heil, Henning Seim
  • Publication number: 20170362506
    Abstract: Liquid-crystalline medium contains at least one compound of formula I, and at least one compound formulae ST-1 to ST-17 and the use thereof for an active-matrix display, in particular based on the VA, PSA, PA-VA, SS-VA, SA-VA, PS-VA, PALC, IPS, PS-IPS, UB-FFS, U-IPS, FFS or PS-FFS effect.
    Type: Application
    Filed: March 10, 2016
    Publication date: December 21, 2017
    Applicant: Merck Patent GmbH
    Inventors: Harald HIRSCHMANN, Sabine SCHOEN
  • Patent number: 9847499
    Abstract: The present invention relates to metal complexes of formula (1), and to electronic devices, in particular organic electroluminescent devices, comprising these metal complexes, in particular as emitters.
    Type: Grant
    Filed: July 17, 2012
    Date of Patent: December 19, 2017
    Assignee: Merck Patent GmbH
    Inventors: Philipp Stoessel, Esther Breuning
  • Publication number: 20170358760
    Abstract: The present invention relates to organic electroluminescent devices which comprise mixtures of at least one phosphorescent material and at least two electron-transporting materials.
    Type: Application
    Filed: October 7, 2015
    Publication date: December 14, 2017
    Applicant: MERCK PATENT GMBH
    Inventors: Philipp STOESSEL, Joachim KAISER, Jonas Valentin KROEBER, Tobias GROSSMAN
  • Publication number: 20170355210
    Abstract: The present invention relates to laser-markable and laser-weldable polymeric materials which are distinguished by the fact that they comprise, as laser absorber, at least one copper-doped zinc sulfide.
    Type: Application
    Filed: November 18, 2015
    Publication date: December 14, 2017
    Applicant: Merck Patent GmbH
    Inventors: Reinhold RUEGER, Ulrich QUITTMANN, Silvia ROSENBERGER
  • Publication number: 20170357131
    Abstract: The invention relates to a light modulation element comprising a polymer stabilized cholesteric liquid crystalline medium sandwiched between two substrates (1), provided with a common electrode structure (2) and a driving electrode structure (3) individually, wherein the substrate with driving and/or common electrode structure is additionally provided with an alignment electrode structure (4) which is separated from the driving and or common electrode structure on the same substrate by an dielectric layer (5), characterized in that the light modulation element comprises at least one alignment layer (6) directly adjacent to the liquid crystalline medium. The invention is further relates to a method of production of said light modulation element and to the use of said light modulation element in various types of optical and electro-optical devices, such as electro-optical displays, liquid crystal displays (LCDs), non-linear optic (NLO) devices, and optical information storage devices.
    Type: Application
    Filed: January 5, 2016
    Publication date: December 14, 2017
    Applicant: MERCK PATENT GMBH
    Inventors: Kuan-Yu CHEN, Ming-Chou WU, Bernd FIEBRANZ, Harald SEIBERT
  • Patent number: 9843004
    Abstract: The present invention relates to novel metal-ligand coordination compounds of the general formula T1-(A-T2)i, where T1 and T2 represent metal-ligand coordination compounds, to the use thereof in a device, and to a formulation and a device which comprise the novel compounds.
    Type: Grant
    Filed: September 10, 2015
    Date of Patent: December 12, 2017
    Assignee: Merck Patent GmbH
    Inventors: Junyou Pan, Rémi Manouk Anémian, Herwig Buchholz
  • Patent number: 9839665
    Abstract: The present invention relates to compounds of the formula (I) and in particular medicaments comprising at least one compound of the formula (I) for use in the treatment and/or prophylaxis of physiological and/or pathophysiological states in the triggering of which cathepsin D is involved, in particular for use in the treatment and/or prophylaxis of arthrosis, traumatic cartilage injuries, arthritis, pain, allodynia or hyperalgesia.
    Type: Grant
    Filed: February 11, 2016
    Date of Patent: December 12, 2017
    Assignee: Merck Patent GmbH
    Inventors: Markus Klein, Christos Tsaklakidis, Hans Guehring, Birgitta Leuthner
  • Publication number: 20170349827
    Abstract: The present invention relates to liquid-crystalline media comprising one or more compounds of formula G and one or more compounds selected from the group of compounds of formulae I, II and III, in which the parameters have the meaning indicated in Claim 1, and to components comprising these media for high-frequency technology, in particular phase shifters and microwave array antennas.
    Type: Application
    Filed: December 14, 2015
    Publication date: December 7, 2017
    Applicant: Merck Patent GmbH
    Inventors: Michael WITTEK, Constanze BROCKE, Volker REIFFENRATH
  • Publication number: 20170351130
    Abstract: The invention relates to a light modulation element, preferably exploiting the flexoelectric effect comprising a cholesteric liquid crystalline medium sandwiched between two substrates (1), each provided with an electrode structure (2), wherein at least one of the substrates is provided with a photoresist pattern consisting of periodic substantially parallel stripes (3) which is additionally provided with an alignment layer (4). The invention is further related to a method of production of said light modulation element and to the use of said light modulation element in various types of optical and electro-optical devices, such as electro-optical displays, liquid crystal displays (LCDs), non-linear optic (NLO) devices, and optical information storage devices.
    Type: Application
    Filed: November 20, 2015
    Publication date: December 7, 2017
    Applicant: MERCK PATENT GMBH
    Inventors: Jonathan GORECKI, Benjamin SNOW, Rachel TUFFIN, Owain Llyr PARRI
  • Publication number: 20170348487
    Abstract: A reloadable auto injector for epinephrine injection is provided. The reloadable auto injector has a separate needle insertion and medicine injection drivers (1600) wherein needle insertion driver (1200) is configured to be re-activated upon reloading. A syringe is movably positioned in a housing between a first position in which the needle is accommodated inside the housing and a second position in which the needle protrudes outside the housing. A plunger rod (1500) is normally locked to a plunger rod tube (1100) by at least one deflectable locking member (1110). A syringe driver (1200) applies a force to the syringe to move the syringe together with plunger rod tube, plunger rod and plunger rod driver from the first position to the second position. In the second position, the locking member (1110) is unlocked and releases the plunger rod to thereby activate the plunger rod driver to advance the plunger rod in the syringe for delivering of medicament.
    Type: Application
    Filed: June 14, 2017
    Publication date: December 7, 2017
    Applicant: MERCK PATENT GMBH
    Inventors: Soeren BECHMANN, Flemming MADSEN, Esben JOHANSEN
  • Publication number: 20170349001
    Abstract: The present invention relates to a process for the production of a pattern having a three-dimensional appearance in a coating comprising flake-form effect pigments, to a coating produced in this way, and to the use thereof.
    Type: Application
    Filed: December 3, 2015
    Publication date: December 7, 2017
    Applicant: Merck Patent GmbH
    Inventors: Peter CLAUTER, Klaus-Christian ULLMANN, Ruediger SMOLKA, Johannes TASCH
  • Publication number: 20170349832
    Abstract: The present invention relates to liquid-crystalline media comprising one or more pleochroic dyes and one or more compounds selected from the group of compounds of formulae I, II and III, in which the parameters have the meaning indicated in Claim 1, and to components comprising these media for high-frequency technology, in particular phase shifters and microwave array antennas.
    Type: Application
    Filed: November 25, 2015
    Publication date: December 7, 2017
    Applicant: Merck Patent GmbH
    Inventors: Michael WITTEK, Dagmar KLASS, Peer KIRSCH